GPhC warns against supply of COVID-19 rapid antibody tests

GPhC warns against supply of COVID-19 rapid antibody tests

July 21, 2020

The General Pharmaceutical Council (GPhC) has stated that it does not believe it is appropriate for COVID-19 rapid antibody tests to be sold in community pharmacies at this time.

In a letter sent to community pharmacy contractors and superintendent pharmacists today, Chief Executive Duncan Rudkin outlined the GPhC’s concerns about the potential for the selling or recommendation of such antibody tests to undermine the standards and professional responsibilities of pharmacy professionals.

Whilst the UK Government, World Health Organization (WHO) and Scientific Advisory Group for Emergencies (SAGE) remain concerned about the use and efficacy of these tests, it is strongly recommended that you ensure your pharmacy does not offer rapid antibody test kits.

As indicated in a PSNC daily update email last month, there is a clear expectation from GPhC that pharmacies will adhere to published guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) and Public Health England. Pharmacists and pharmacy technicians should ensure they are up-to-date with national guidance issued by Government bodies and consider the wider public health impact of supplying or advising any activity that may contribute to false assurances.

Read the GPhC letter about rapid antibody tests

Posted in: , , ,

More Latest News >